Physician profile
Stephen David Blake
NPI 1538111588
$1,981.37
in general payments reported to CMS, 2019-2025
17 companies · $79.89 in 2025
The $79.89 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $331 · 2020: $130 · 2021: $224 · 2022: $293 · 2023: $246 · 2024: $678 · 2025: $79.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,004.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,003.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $643.93 | 2019-2024 | Jornay Pm |
| Supernus Pharmaceuticals, INC. | $342.50 | 2021-2024 | Qelbree, Qelbree |
| Corium, LLC | $330.82 | 2021-2024 | Azstarys |
| Pfizer INC. | $145.81 | 2019-2021 | |
| Tris Pharma INC | $95.37 | 2019-2022 | |
| Glaxosmithkline, LLC. | $82.12 | 2024 | Bexsero |
| Genentech USA, INC. | $61.29 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $37.82 | 2025 | Jornay Pm |
| Astrazeneca Pharmaceuticals LP | $36.54 | 2023-2025 | Flumist Quadrivalent |
| Cranial Technologies, INC | $33.14 | 2020-2023 | Doc Band |
| Neos Therapeutics, LP | $32.60 | 2019-2020 | |
| Adlon Therapeutics L.P. | $32.42 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $29.12 | 2019 | |
| Nestle Healthcare Nutrition INC. | $21.71 | 2023 | |
| Phadia US INC. | $21.71 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alk-Abello, INC | $21.46 | 2025 | Neffy, Odactra, Ragwitek |
| Shire North American Group INC | $13.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Blake listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.